| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.5546 | 15 |
| GSM780708 | Untreated after 4 days (C2_1) | 41.157 | 10 |
| GSM780709 | Untreated after 4 days (C3_1) | 40.5855 | 8 |
| GSM780719 | Untreated after 4 days (C1_2) | 40.7978 | 9 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.9047 | 22 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.1754 | 23 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 36.7061 | 1 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.6181 | 16 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.3104 | 19 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.0902 | 37 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.5159 | 34 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.7607 | 26 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 39.3477 | 5 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 37.6392 | 2 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 34.8963 | 1 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.6874 | 21 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 38.4224 | 3 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.0261 | 10 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.8634 | 13 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.0076 | 27 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 37.4811 | 2 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 40.4188 | 8 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 37.0806 | 2 |